Asensus Surgical to Participate in the 40th Annual J.P. Morgan Healthcare Conference and H.C. Wainwright Bioconnect 2022 Conference
December 29 2021 - 6:55AM
Business Wire
Asensus Surgical, Inc. (NYSE American: ASXC) announced today
that Anthony Fernando, President and Chief Executive Officer, and
Shameze Rampertab, Executive Vice President and Chief Financial
Officer, will participate in the 40th Annual J.P. Morgan Healthcare
Conference. The Company’s virtual presentation will take place on
Thursday, January 13, 2022 at 9:00 am Eastern Time.
In addition, the Company will participate in the H.C. Wainwright
Bioconnect 2022 Conference during the week of January 10th. A
pre-recorded fireside chat will be available on-demand beginning
Monday, January 10, 2022 at 7:00 am Eastern Time.
Both conference webcasts will be available online on the
investor relations page of the Company’s website at
https://ir.asensus.com/events-and-presentations. Replays of the
webcasts will be archived on the website for approximately 90
days.
About Asensus Surgical, Inc.
Asensus Surgical, Inc. is digitizing the interface between the
surgeon and patient to pioneer a new era of Performance-Guided
Surgery™ by unlocking clinical intelligence for surgeons to enable
consistently superior outcomes and a new standard of surgery. This
builds upon the foundation of Digital Laparoscopy with the
Senhance® Surgical System powered by the Intelligent Surgical Unit™
(ISU™) to increase surgeon control and reduce surgical variability.
With the addition of machine vision, augmented intelligence, and
deep learning capabilities throughout the surgical experience, we
intend to holistically address the current clinical, cognitive and
economic shortcomings that drive surgical outcomes and value-based
healthcare. Learn more about Performance-Guided Surgery and Digital
Laparoscopy with the Senhance Surgical System here:
www.senhance.com. Now available for sale in the US, EU, Japan,
Russia, and select other countries. For a complete list of
indications for use, visit: www.senhance.com/indications. For more
information, visit www.asensus.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211229005052/en/
INVESTOR CONTACT: Mark Klausner or Mike Vallie, 443-213-0499
invest@asensus.com or MEDIA CONTACT: Kristin Schaeffer,
858-354-8850 CG Life kschaeffer@cglife.com
Asensus Surgical, Inc. (NYSE:ASXC)
Historical Stock Chart
From Jul 2024 to Aug 2024
Asensus Surgical, Inc. (NYSE:ASXC)
Historical Stock Chart
From Aug 2023 to Aug 2024